Clinical trial
The Role of 5-alpha Reductase in Mediating Testosterone Actions
NCT00493987 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00493987 |
|---|---|
| Title | The Role of 5-alpha Reductase in Mediating Testosterone Actions |
| Official title | The Role of 5-alpha Reductase in Mediating Testosterone Actions |
| Acronym | 5aR |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Testosterone Enanthate, Dutasteride |
| Enrollment | 184 |
| Start date | Nov 1, 2002 |
| Primary completion | Dec 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Jun 29, 2007 |
| Last update posted | May 13, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: